MedPath

Study of Virasika and Dadima Yusha as diet in enhancing the therapeutic effect of Yoga Basti in childre

Phase 2
Conditions
Health Condition 1: Q00-Q99- Congenital malformations, deformations and chromosomal abnormalitiesHealth Condition 2: L00-L99- Diseases of the skin and subcutaneous tissueHealth Condition 3: F01-F99- Mental, Behavioral and Neurodevelopmental disordersHealth Condition 4: E889- Metabolic disorder, unspecified
Registration Number
CTRI/2023/09/057679
Lead Sponsor
Dr Syeda Maimunna Begum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Children between the age group of 5 to 10 years, irrespective of their gender, religion and

socio-economic status will be included.

2. Children who are Arha (eligible) for Basti Karma will be included in the study.

3. Children whose parents are willing to sign the written consent form and to follow the treatment

protocol will be included.

Exclusion Criteria

1) Children below 5 years and above 10 years of age will be excluded.

2) Children with neuromuscular diseases having difficulties in deglutition will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
In Samyak Niruha & Anuvasana Lakshanas, effect of Samsarjana Krama will be assessed based on the following parameters <br/ ><br>1.Proper evacuation of feces,urine and flatus. <br/ ><br>2.Improvement in sleep quality. <br/ ><br>3.Improvement in digestion.Timepoint: specific pathya aahara will be provided for a period of 8 days during the course of yoga basti in children.
Secondary Outcome Measures
NameTimeMethod
Agnibala will be assessed by <br/ ><br>1. Assessment of Abhyavaharana shakti <br/ ><br>2. Assessment of Jarana shakti.Timepoint: specific pathya aahara will be provided for a period of 8 days during the course of yoga basti in children
© Copyright 2025. All Rights Reserved by MedPath